Navigation Links
Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
Date:11/5/2007

chnology companies. For additional information about Paramount BioSciences, please visit http://www.paramountbio.com.

About TRB Chemedica

TRB Chemedica is a privately-owned Swiss pharmaceutical company with more than 20 years experience in research, development, manufacture and commercialization of innovative niche products in rheumatology, ophthalmology and neurology. TRB Chemedica has developed an expertise on the viscoelastic biopolymer, hyaluronic acid, manufacturing sterile finished products in its Swiss-based GMP facility. The company's product pipeline will help to fuel growth in each of the targeted therapeutic areas as well as introduce it into new areas of therapeutic focus. TRB Chemedica products are currently sold in more than 40 countries worldwide through wholly-owned subsidiaries, present in various countries in Europe, South America and Asia, and a growing network of licensing and distribution partners. For more information on TRB Chemedica visit the Company's web site at http://www.trbchemedica.com.

Caution Concerning Forward-Looking Statements. This press release might contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Lantibio's expectations and projections. Risks and uncertainties include success of clinical trials for Lantibio's products, intellectual property risks, need for additional financing or capital, ability to develop and successfully commercialize our products, ability to enter into licensing agreements, and the ability of the competition to render Lantibio's product candidates or technologies obsolete or noncompetitive. Lantibio assumes no obligation to updat
'/>"/>

SOURCE Lantibio, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008).../ -- BioTrends Research Group, Inc.,released its 1...cation, a,syndicated report offering comprehensive...one and mineral metabolism in Chronic Kidney Disea...tion from 182 US,Nephrologists -- data were collec..., In the renal anemia market, while the use of ES...
(Date:7/25/2008)...rstCall/ -- Caraco Pharmaceutical,Laboratories, Lt...arter of,Fiscal 2009, ended June 30, 2008, of $108...orresponding period of Fiscal 2008. This represent...scal 2008. Pre-tax income grew,to $14.6 million fo...a,pre-tax income of $9.6 million during the corres...
(Date:7/25/2008)...ain Hearing in Both Ears for the First ...25 /- Cochlear, the world,s leader in...landmark milestone when,Dr. Thomas Roland, Jr., MD...0th cochlear implant device procedure. Today, 72-y...dergo surgery to receive bilateral (a,device in ea...
(Date:7/25/2008)...survey on creativity, sponsored by the Jerusalem-b...Teleseker, revealed that a majority of the Israeli...special methods that could "put them into a c...ong as desired." , J... survey on creativity, sponsored by the Jerusalem-...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 2Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 3Cochlear Announces Milestone in Hearing Restoration With 120,000 Nucleus(R) Cochlear Implants 4Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 2Project Mind Survey of Israeli Ph.D. Scientists Favors a New Standard of Creativity in Science 3
... of manufacturing jobs that have vanished all thro...ore smokestack industries is a fool,s errand. Inst...f companies based on the technological inventions ...cation and private industries. , ,Several economic...nt of assisting these technol with high growth pot...
...licants has been winnowed to 52 in the Second Ann... ,An independent panel of judges selected the surv... The judges were organized through the Wisconsin ...t in conjunction with its membership subsidiary, t...de affiliates. , ,"Our judges were impressed by th...
...d out last week, Mondays Wall Street Journal det..., ,In past columns, we have talked about the conso...nese are actually arriving late to the consolidati...ave been consolidating for years and continue to c...ove that did not acquire other major pharmaceuti...
...here may no yellow tape or chalk outlines of a bod...uter crimes if they want remedies, said a lawyer w... Wednesday. , ,Daniel Vaccaro, a partner with Mic...ose systems have been compromised by Internet frau...earning to work with law enforcement. , ,"You get ...
Other Biology Technology:Will tech transfer save Wisconsin's economy? 2Will tech transfer save Wisconsin's economy? 3Will tech transfer save Wisconsin's economy? 4Will tech transfer save Wisconsin's economy? 5Will tech transfer save Wisconsin's economy? 6Will tech transfer save Wisconsin's economy? 7Will tech transfer save Wisconsin's economy? 8Contest narrows to 52 business plans 2Japan's pharma mergers will trickle to the Midwest 2Japan's pharma mergers will trickle to the Midwest 3Japan's pharma mergers will trickle to the Midwest 4After a successful attack on your computer systems, then what? 2After a successful attack on your computer systems, then what? 3
(Date:7/24/2008)...w study by researchers from Columbia University,s ...he most challenging issues in infant health and pr...countries. In these settings, HIV-infected mother...heir infants, they should exclusively breast-feed,...ter birth. But according to the study conducted in...
(Date:7/24/2008)...4, 2008 In the life of a cell, the response to DN...ause and repair itself, commit suicide, or grow un...study, published in the July 25th issue of Cell ,...ntified a way that cells respond to DNA damage thr... The finding points to a new pathway for the devel...
(Date:7/24/2008)...AUL (July 24, 2008) A multi-institutional team of...ty of Minnesota Medical School, have developed a p...e robust method will allow researchers to generate...DNA sequences for inactivation or repair. , The p...Ph.D., director of the Arnold and Mabel Beckman Ce...
(Date:7/24/2008)...Y, Iowa The University of Iowa and Iowa State Uni...ly enhance both institutions, genetic research cap...hased a massively parallel DNA sequencer an instr...rate of millions to billions of bases in a single ... will be available on a fee-for-service basis to ...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3A new cellular pathway linked to cancer is identified by NYU researchers 2Consortium develops new method to manipulate genetic material 2UI and ISU establish shared DNA sequencing instrumentation 2UI and ISU establish shared DNA sequencing instrumentation 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 1New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 2New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 3New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 4New Data Suggest Cymbalta 28R 29 Reduced Pain in Fibromyalgia Patients With and Without Depression 110 5Sinovac Announces Postponement of Annual General Meeting 115 1Sinovac Announces Postponement of Annual General Meeting 115 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 1Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 2Dr Amit Dhawan Promoted to Medical Director for The Mattson Jack Group 114 3Longer ambulance journeys boost death risk for seriously ill patients 116 1Longer ambulance journeys boost death risk for seriously ill patients 116 2
... in the brilliantly colored,hot springs of Yellows..., a discovery University of Colorado at Boulder re...onments on other planets and could,add to understa... CU-Boulder biologists led by Professor Norman Pac... evolution and microbiology,published their repor...
...at broadens our insight into,the cause of certain ...asmus University Medical Center (Rotterdam, The Ne... enzyme-repair system to identify the,principal ty...-tumor,development. The researchers, findings also...developing preventative therapies against skin,can...
... skin and bones, which could,be used to treat burn...igurements, may soon be a reality using inkjets wh...rsity of Manchester have developed the,breakthroug...and bones,to be grown, simply by inputting their d..., Head of the Ink-Jet Printing of Human Cells Proj...
...searchers from the Departments,of Chemical and Env...,Botany and Plant Sciences have worked together to...ates ,to uncover new knowledge about the binding o...rotein plays a critical role along with another,pr...tubes to the eggs,found in ovules. , Applying,nano...
Other Biology News:Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 2Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 3Yellowstone microbes fueled by hydrogen, according to U. of Colorado study 4Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer 2University of Manchester makes made-to-measure skin and bones a reality using inkjet printers 2Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants 2
RAT ANTI MOUSE JAM-2 Immunogen: Recombinant soluble JAM-2
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds
...y RNA Spikes for the normalization and control of ...ng and for protocol assessment and optimization. C...ybridization stringency and background. Normalize ...Spots, and complementary RNA Spikes for the normal...
Kit for Detection of Mitochondrial Membrane Potential
Biology Products: